Skip to content
sellWeak10b5-1 plan

Hoge Stephen sold $13k of MRNA

President at Moderna, Inc.. 277 shares at an average of $46.10, traded Nov 11, 2024, filed Nov 12, 2024.

Warning score
0
Value
$13k
277 shares
Holdings after
1,443,248
-0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

The components behind this score (role, size, price context, cluster, track record, modifiers) are shown to Pro users. Start with Pro

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001127602-24-026997, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 8, 2024MOption exercise
Common Stock10b5-1
+523--1,443,525Nov 12, 2024
Nov 11, 2024SOpen-market sale
Common Stock10b5-1
-277$46.10$13k1,443,248Nov 12, 2024
Nov 8, 2024MOption exercise
Restricted Stock Unitsderivative10b5-1
-523$0.00$0523Nov 12, 2024

Related signals

Other insiders at Moderna, Inc. and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
50ModeratebuyMRNA
Moderna, Inc.
Bancel Stephane
Chief Executive Officer
$5.0M160,314
0Weaksell 310b5-1MRNA
Moderna, Inc.
Klinger Shannon Thyme
Chief Legal Officer
$24k529
0Weaksell 310b5-1MRNA
Moderna, Inc.
Hoge Stephen
President
$14k314
0Weaksell 310b5-1MRNA
Moderna, Inc.
Klinger Shannon Thyme
Chief Legal Officer
$4,849112
0Weaksell 310b5-1MRNA
Moderna, Inc.
Hoge Stephen
President
$12k291
2Weaksell 310b5-1MRNA
Moderna, Inc.
Klinger Shannon Thyme
Chief Legal Officer
$61k1,418
14Weaksell 310b5-1MRNA
Moderna, Inc.
Mock James M
Chief Financial Officer
$61k1,420

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Hoge Stephen sold $13k of MRNA | InsiderTell